Rapidly progressive glomerulonephritis epidemiology and demographics: Difference between revisions
| Line 6: | Line 6: | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
===Incidence=== | ===Incidence=== | ||
* | * The [[incidence]] of rapidly progressive glomerulonephritis is around 1 per million individuals per year.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }}</ref> | ||
* In the United Kingdom, the incidence of rapidly progressive glomerulonephritis is estimated to be 2 per 100,000 individuals. | |||
* In Sweden, the incidence of rapidly progressive glomerulonephritis is estimated to be 1 case per 100,000 persons. | |||
===Age=== | ===Age=== | ||
Revision as of 18:37, 31 May 2018
|
Rapidly progressive glomerulonephritis Microchapters |
|
Differentiating Rapidly progressive glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Rapidly progressive glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis epidemiology and demographics |
|
FDA on Rapidly progressive glomerulonephritis epidemiology and demographics |
|
CDC on Rapidly progressive glomerulonephritis epidemiology and demographics |
|
Rapidly progressive glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Rapidly progressive glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Rapidly progressive glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Epidemiology and demographics
Incidence
- The incidence of rapidly progressive glomerulonephritis is around 1 per million individuals per year.[1]
- In the United Kingdom, the incidence of rapidly progressive glomerulonephritis is estimated to be 2 per 100,000 individuals.
- In Sweden, the incidence of rapidly progressive glomerulonephritis is estimated to be 1 case per 100,000 persons.
Age
- The prevalence of rapidly progressive glomerulonephritis increases with age.
Race
- Rapidly progressive glomerulonephritis is more prevalent in the white race more than the black race.
Gender
- Men and women are affected equally by rapidly progressive glomerulonephritis.
References
- ↑ Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.